Is 'Sticky Gunk' In Your Brain The Reason Behind Alzheimer's Disease?

Updated Mar 20, 2025 | 08:53 AM IST

SummaryThe new findings is based on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight years.
Alzheimer's Disease

Credits: Canva

An experimental treatment happens to be the solution to delay Alzheimer's symptoms in some people. These people are the ones who are genetically destined to get the disease in their 40s or 50s. These new findings form ongoing research has now been caught up in Trump administration funding delas. The early results of the study has been published on Wednesday and the participants too are worried that politics could cut their access to a possible lifeline.

One of the participants had said, "It is still a study but it has given me an extension to my life that I never banked on having." The participant is named Jake Henrichs, form New York City, who is 50 years old. He is one of them to be treated in that study for more than a decade now and has remained symptom-free despite inheriting an Alzheimer's-causing gene that had killed his father and brother around the same age.

Slowing Down The Symptoms

Two drugs which can modestly slow down early-stage Alzheimer's are sold in the United States. These drugs clear the brain of one of its hallmarks, a sticky gunk-like part called the amyloid. However, there have not been any hints that removing amyloid far earlier, way many years before the first symptoms appear, may postpone the disease.

How Was The Research Conducted?

The research is led by Washington University in St Louis, which involved families that passed down rare gene mutation as participants. This meant it was almost guaranteed that they will develop symptoms at the same age their affected relatives did.

The new findings is based on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight years. Long-term amyloid removal cut in half their risk of symptom onset. The study is published in the journal Lancet Neurology.

Washington University's Dr Randall Bateman, who directs the Dominantly Inherited Alzheimer's Network of studies involving families with these rare genes says, "What we want to determine over the next five years is how strong is the protection. Will they ever get the symptoms of Alzheimer’s disease if we keep treating them?”

The researchers before though did not know what exactly caused Alzheimer's which affects nearly 7 million Americans, most of them in their later life. However, it is clear that these silent changes occur in the brain at least two decades before the first symptom shows up. The big contributor. At some point amyloid buildup can trigger a protein named tau that then starts to kill neurons, which can lead to cognitive decline.

Researchers are now thus studying the Tau-fighting drugs and are looking into other factors, like inflammation, brain's immune cells and certain virus.

The National Institute of Health (NIH) has expanded its focus as researchers have found more reasons for Alzheimer's. In 2013, the NIH's National Institute on Aging funded 14 trials of possible Alzheimer's drugs over a third targeting amyloid. By last fall, there were 68 drugs and 18% of them target amyloid. However, there are scientists too who think that amyloid is not everything and their is way more in the brain tissue, immune cells, and more which can be studied.

End of Article

Dr Sivaranjani Santosh: How India’s ‘ORS Lady’ Helped Slash Rare Disease Drug Cost From ₹9 Crore To ₹2.5 Lakh

Updated Nov 20, 2026 | 04:19 PM IST

SummaryDr Sivaranjani Santosh has helped bring down the cost of tiratricol treatment for children with Allan-Herndon-Dudley syndrome. Seven children will receive the medicine free for a year. She has urged the Indian government to support domestic compounding and ensure the drug is available in the country.
Dr Sivaranjani Santosh: How India’s ‘ORS Lady’ Helped Slash Rare Disease Drug Cost From ₹9 Crore To ₹2.5 Lakh

Credit: TImes Now

Hyderabad-based paediatrician Dr Sivaranjani Santosh has once again demonstrated how a doctor's efforts can extend beyond the clinic. Widely known as the "ORS Lady of India" for her eight-year campaign against sugary beverages falsely marketed as oral rehydration solutions (ORS), she has now helped make a rare disease medicine significantly more affordable.

Through her efforts and collaboration with international organisations, the estimated annual cost of tiratricol treatment for children with Allan-Herndon-Dudley syndrome (AHDS) has fallen from ₹9 crore to approximately ₹2.5 lakh per child.

AHDS, also known as monocarboxylate transporter 8 (MCT8) deficiency, is a rare X-linked genetic disorder that disrupts brain development and movement, primarily affecting males. It is caused by mutations in the SLC16A2 gene, which encodes the protein responsible for transporting thyroid hormones into brain cells.

Seven children with the condition are set to receive a year's supply of tiratricol free of cost on November 30.

"Feeling so relieved! It had been a roller coaster ride!" Dr Sivaranjani shared in a post on X.

How Did Dr Sivaranjani Reduce The Drug Cost?

Also read: ‘Enough of Toxicity, I’ll Fight It Alone,’ Says Dr Sivaranjani Santosh After Resigning from IAP | EXCLUSIVE

The initiative began after Arav, a child under Dr Sivaranjani's care, was diagnosed with AHDS. His mother, Pavitra, was paying approximately ₹12 lakh to ₹13 lakh for a month's supply of the medicine from Germany.

Although tiratricol was available in Europe, its commercial price made it unaffordable for most families. A compounded formulation prepared by Netherlands-based Transvaal Pharmacy is estimated to cost just ₹2.5 lakh per child for a year.

Tiratricol, also known as TRIAC, is a thyroid hormone analogue that helps address hormonal imbalances associated with MCT8 deficiency and reduce complications linked to excess thyroid hormone activity in peripheral tissues.

Transvaal Pharmacy prepared the formulation with support from the Netherlands-based Pharmaceutical Accountability Foundation (PAF).

The medicine has reached India through the appropriate channels and with the necessary permissions. It will be handed over to the seven families, who have secured approvals for one year of treatment.

"Parents of those children I am a paediatrician for donated generously, and Pharmaceutical Accountability Foundation raised funds too. So, the parents of these seven children didn't have to pay a single rupee for the medicine," Dr Sivaranjani said.

As the medicine has a six-month shelf life, it will be imported in two batches, The Hindu reported.

Who Is Funding The Treatment?

Read More: Rare Diseases Day: How AI Is Transforming Early Diagnosis

According to PAF, providing one year's treatment to all seven children will cost €14,200, approximately ₹15.08 lakh.

Dr Sivaranjani raised approximately ₹6.09 lakh in India, while PAF undertook to raise the remaining €8,600, approximately ₹9.13 lakh, in the Netherlands.

The contributions will ensure that all seven families receive the medicine free of cost.

Dr Sivaranjani Calls For Make In India

Attempts to access tiratricol through Egetis Therapeutics' compassionate-use programme failed. On September 7, Dr Sivaranjani appealed for help on social media, bringing the case to the attention of PAF. The foundation then worked with Transvaal Pharmacy to develop a compounded formulation using the active pharmaceutical ingredient for the seven children.

Calling the situation an example of "pharma piracy", Dr Sivaranjani questioned why a medicine that could be compounded for approximately ₹2.5 lakh was being made inaccessible to families through commercial

pricing of around ₹9 crore.

Dr Sivaranjani has urged the Indian government to enable domestic compounding of the active pharmaceutical ingredient (API) and make the medicine available under the National Policy for Rare Diseases. "We can easily prepare it here, and it would cost even less," she said.

End of Article

Measles Vaccine, Autism & Tylenol: RFK Jr's Most Controversial Health Claims

Updated Nov 20, 2026 | 07:00 AM IST

SummaryHealth and Human Services Secretary Robert F. Kennedy Jr., a long-time vaccine skeptic, has made several ill-founded health claims about vaccine-autism, MMR vaccine, raw milk, Tylenol-autism and many more.
Measles Vaccine, Autism & Tylenol: RFK Jr's Most Controversial Health Claims

Credit: AI

As the United States lost its measles elimination status of more than 25 years, Health and Human Services Secretary Robert F. Kennedy Jr. and his long record of challenging established public health norms and policies are being heavily scrutinised.

The US has reported more than 5,700 measles infections and 11 deaths in 2026, amid an alarming decline in childhood vaccination coverage in several states.

A recent Reuters investigation examined how vaccine skepticism and gaps in outbreak response have contributed to the country's measles crisis.

Kennedy, a longtime vaccine skeptic, had made several controversial health claims about several things like removing fluoride in drinking water, promoting raw milk, linking tylenol and autism, COVID-19 and cellphone radiation.Some of his concerns relate to legitimate areas of scientific debate but many others clash with established evidence.

Robert F. Kennedy Jr. Most Controversial Health Claims

1. Vaccines Cause Autism

Vaccine-autism controversy dates back to a 1998 study which suggested a link between the MMR vaccine and autism. The paper was subsequently retracted.But Kennedy has been a long-time skeptic of vaccines, questioning their efficacy and safety on multiple occasions.

He has repeatedly argued that vaccines can contribute to autism as their ingredients and childhood immunisation schedules have not been adequately studied.

But extensive research has found no relationship between vaccines and autism. A World Health Organization review published in September 2026 examined studies published between 2010 and August 2025 and defied this claim.

Also read: World Immunization Day: Former CDC Advisor Explains Why The Vaccine-Autism Myth Is So Hard To Debunk

2. The MMR Vaccine Should Be Split Into Separate Shots

Kennedy has also questioned the safety of the combined measles, mumps and rubella (MMR) vaccine, supporting President Trump's proposal to separate the three vaccines.

In August 2026, he defended an executive order calling to pursue the option of separating the combination vaccine. He also cited research that he said supported the move.

However, vaccine experts have said there is no evidence that splitting the MMR vaccine makes it safer or reduces autism risk. In fact, they said that separating the shots could also mean more injections and delays in completing vaccination, leaving children vulnerable to infection.

3. Raw Milk Is Healthier Than Pasteurised Milk

Kennedy has advocated for raw, unpasteurised milk, claiming it is healthier than pasteurised milk and that it is better for gut health. However, the US Food and Drug Administration (FDA) says these benefits have not been scientifically backed.

Pasteurisation involves heating milk to eliminate harmful microorganisms. Raw milk can carry pathogens like E. coli, Salmonella, Listeria and Campylobacter, which can cause serious foodborne illness.

The FDA has documented outbreaks due to contaminated raw milk, including illnesses involving kidney failure and pregnancy complications.

Also read: 'It’s The Best-Studied Vaccine In Human History': Former CDC Adviser Busts Common Myths About COVID Vaccines

4. Fluoride In Drinking Water Is Harmful

Kennedy has called fluoride an industrial waste product and pushed for its removal from public water supplies.

There is a legitimate scientific discussion about fluoride exposure at high levels. A US National Toxicology Program review found that higher fluoride exposures, especially those above recommended drinking-water levels, were linked to lower IQ scores in children.

But it does not prove that fluoride at the levels used in community water fluoridation produces the same effects.

The US Centers for Disease Control and Prevention (CDC) continues to support community water fluoridation at the recommended concentration of 0.7 milligrams per litre. It considers this an effective way to prevent tooth decay.

5. Ivermectin And Hydroxychloroquine & COVID-19 Deaths

During the COVID-19 pandemic, Kennedy argued that more use of ivermectin and hydroxychloroquine could have reduced deaths. But subsequent clinical trials and systematic reviews did not establish that either drug improved any outcome for people with COVID-19.

A 2025 systematic review and network meta-analysis published in the BMJ, covering hundreds of trials, found that neither ivermectin nor hydroxychloroquine reduced hospital admissions or mortality compared to routine treatments in people with COVID-19.

Also read: EXCLUSIVE: Ex-CDC Vaccine Advisor Says Measles Outbreak Bigger Than Reported, Slams RFK Jr’s ‘No-See Evil’ Approach

6. Tylenol Use During Pregnancy May Cause Autism

Kennedy has also spoken against acetaminophen, sold under the brand name Tylenol, and its role in autism risk when used during pregnancy.

It attracted scientific attention as some studies observed links between prenatal acetaminophen exposure and neurodevelopmental conditions. But evidence is still inconclusive.

In September 2025, the FDA acknowledged that evidence suggesting a possible link but explicitly stated that it had not been established thoroughly.

Kennedy has also claimed that circumcision can cause autism, which is, too, not supported by science.

7. Seed Oils Are A Major Cause Of Chronic Inflammation

As part of his Make America Healthy Again agenda, Kennedy criticised seed oils, including soybean, corn, canola and sunflower oils, suggesting that they cause inflammation and chronic disease. He also promoted alternatives like beef tallow.

But evidence does not support that seed oils are inherently harmful. These oils contain unsaturated fats and replacing saturated fats with polyunsaturated fats can help lower LDL cholesterol, which is a risk factor for cardiovascular disease.

The American Heart Association's 2026 dietary guidance supports replacing sources of saturated fat, including butter and beef tallow, with oils rich in unsaturated fats.

8. Wi-Fi And Cellphone Radiation Can Cause Cancer

Kennedy has warned that electromagnetic radiation from wireless devices could damage mitochondria, disrupt biological processes and increase cancer risk.

Cellphones emit radiofrequency radiation, which is non-ionising and does not have enough energy to directly damage DNA in the way that ionising radiation, like X-rays, can.

The US National Cancer Institute says that evidence to date suggests cellphone use does not cause brain or other cancers in humans.

9. Childhood Vaccines Are Inadequately Tested For Safety

Kennedy has repeatedly questioned whether childhood vaccines have been tested for safety sufficiently, arguing that many have not been evaluated in placebo-controlled trials. This claim can be misleading as it deems only one type of trial as acceptable and safe.

Vaccines undergo clinical testing before approval. Their safety and effectiveness are evaluated through different study designs. Depending on the vaccine, trials may compare a new vaccine with an existing vaccine or another appropriate control rather than a placebo.

10. Different Vaccination Schedules For Different Races

In a 2021 interview, Kennedy suggested that Black Americans should follow a different vaccination schedule from white Americans, claiming that Black people had stronger immune systems and could be more vulnerable to vaccine’s side effects.

Medical experts defied the argument as scientifically unreliable. There is no established basis for assigning vaccination schedules according to race.

Vaccine recommendations are based on factors like age, medical history, immune status, exposure risk and other clinical considerations.

End of Article

Olivia Munn, Senator Mark Kelly Push For Breast Cancer Bill In US: What To Know

Updated Nov 19, 2026 | 09:49 PM IST

SummaryOlivia Munn and US Senator Mark Kelly have introduced the Know Your Risk Act to expand access to validated breast cancer risk assessment tools, helping women and their doctors understand individual risk and make informed screening decisions.
Olivia Munn, Senator Mark Kelly Push For Breast Cancer Bill In US: What To Know

Credit: Mark Kelly/X

Actress Olivia Munn has joined US Senator Mark Kelly to push for legislation that would make breast cancer risk assessments a routine part of healthcare for American women, helping them understand their individual risk and access appropriate screening.

Together, they have introduced the Know Your Risk Act, which aims to expand access to validated breast cancer risk assessment tools and integrate them into routine healthcare.

Munn, who was diagnosed with breast cancer in 2023, said a risk assessment prompted her doctor to recommend further testing despite her having a normal mammogram and negative genetic testing. The additional tests detected an aggressive cancer early.

"Had it not been for that assessment, my breast cancer may not have been identified when it was," Munn said while announcing the legislation alongside Kelly.

Also read: World Breast Cancer Day 2026: Life After Breast Cancer, The Fear No One Sees

What Is The Know Your Risk Act?

Announcing the legislation outside the US Capitol, Kelly said existing breast cancer risk assessment tools are not being used widely enough, leaving many women unaware of their individual risk.

"These tools already exist, but too often doctors aren't using them and women don't know that they're available," Kelly said.

The Democratic senator from Arizona said the Act would make breast cancer risk assessments a routine part of healthcare, helping women and their doctors understand individual risk and determine appropriate screening.

"Women shouldn't have to ask for these assessments. They should be part of regular care like getting a blood pressure reading taken," Kelly said.

He added that the legislation had bipartisan support, with lawmakers recognizing the importance of expanding access to early detection.

Why Is Breast Cancer Risk Assessment Important?

Read More: Breast Cancer At 26 Sent This US Woman Into Menopause Before 30: What Is The Hidden Toll Of Treatment

Munn's experience highlights why individual risk assessments matter, particularly when standard screening and genetic testing may not identify a woman's breast cancer risk.

Despite having a normal mammogram and negative genetic testing, her risk assessment prompted further investigations that led to her diagnosis.

She said the experience motivated her to work with Kelly to ensure other women have access to similar assessments.

According to the World Health Organization (WHO), breast cancer caused an estimated 694,000 deaths worldwide in 2024. It was the most commonly diagnosed cancer among women in 164 of 186 countries.

In the US, breast cancer is the second leading cause of cancer death among women, according to the Centers for Disease Control and Prevention (CDC).

Early Breast Cancer Detection Can Improve Survival

Early detection can significantly improve breast cancer outcomes. According to the National Cancer Institute, the five-year relative survival rate for women with localized breast cancer is more than 99%.

During the announcement, a representative of breast cancer organization Susan G. Komen highlighted the difference between detecting the disease before and after it spreads, noting that survival rates can fall to around 30% when breast cancer is diagnosed at a distant stage.

The representative also pointed to the rising number of diagnoses among women under 50, many of whom may not consider themselves at risk.

The Know Your Risk Act seeks to address this gap by expanding access to validated risk assessment tools, helping women and their doctors better understand individual risk and make informed decisions about screening.

End of Article